| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 19,141 | 9,334 |
| Depreciation | 580 | 415 |
| Amortization of intangibles | 6,670 | 4,069 |
| Stock-based compensation | 55,616 | 36,639 |
| Deferred tax expense | 9,337 | 2,671 |
| Accounts receivable | 176,544 | 121,497 |
| Prepaid expenses and other current assets | 3,038 | 21,344 |
| Other non-current assets and right-of-use asset | -2,345 | -1,056 |
| Accounts payable and accrued expenses | 2,682 | -7,687 |
| Provider liability | 118,815 | 81,185 |
| Operating lease liabilities | -1,187 | -778 |
| Other long-term liabilities | 1,487 | -153 |
| Net cash provided by operating activities | 35,904 | -16,090 |
| Business acquisitions, net of cash acquired | 89,058 | 89,058 |
| Other | 1,200 | 0 |
| Net cash used in investing activities | -90,258 | -89,058 |
| Proceeds from exercised stock options | 4,557 | 4,126 |
| Proceeds from non-controlling interest | 0 | 0 |
| Net cash provided by financing activities | 4,557 | 4,126 |
| Net (decrease) increase in cash and cash equivalents | -49,797 | -101,022 |
| Cash and cash equivalents at beginning of period | 491,149 | - |
| Cash and cash equivalents at end of period | 441,352 | - |
Privia Health Group, Inc. (PRVA)
Privia Health Group, Inc. (PRVA)